Rising to the
challenges of
Immuno-Oncology

Cancer is said to affect one out of every two Japanese people.
In the 1990s, Ono Pharmaceutical participated in a joint research project with a university, taking the first step into the field of Immuno-Oncology.
At the time, Immuno-Oncology was an unknown area in medical care, and there were many negative voices, which made research and development extremely difficult.
Nevertheless, we did not give up, because we had an ardent desire to contribute to patients.
Now, Ono Pharmaceutical continues to be a pioneer in drug development in the field of Immuno-Oncology, aiming to create breakthrough cancer drugs,
and will continue on this path in the future.

Cancer is said to affect one out of
every two Japanese people.
In the 1990s, Ono Pharmaceutical participated
in a joint research project with a university, taking the first step into the field of Immuno-Oncology.
At the time, Immuno-Oncology was an unknown area in medical care, and there were many negative voices, which made research and development extremely difficult.
Nevertheless, we did not give up, because we had an ardent desire to contribute to patients.
Now, Ono Pharmaceutical continues to be a pioneer in drug development in the field of Immuno-Oncology, aiming to create breakthrough cancer drugs,
and will continue on this path in the future.

Cancer Treatment
Options

The three major cancer treatment options have
long been referred to as “surgery,” “radiation therapy,”
and “anticancer drug therapy.”
In recent years, new treatments that use newly
established aspects of the body's immune system
to attack cancer have become widely available.
This approach has led to a number of new drugs
that are gaining acceptance as the fourth option
in cancer treatment.

The three major cancer treatment options
have long been referred to as “surgery,”
“radiation therapy,” and “anticancer drug therapy.”
In recent years, new treatments that use newly
established aspects of the body's immune system
to attack cancer have become widely available.
This approach has led to a number of new drugs
that are gaining acceptance as the fourth option
in cancer treatment.

BREAK THROUGH

Embrace the Challenge with ONO

Based on its corporate philosophy,
"Dedicated to the Fight against Disease and Pain,"
Ono Pharmaceutical has been delivering hope to patients
and their families by creating innovative drugs.
New drugs are approved after overcoming
many challenges and failures.
We believe that taking on new challenges in this manner
will lead to a bright future, and we will continue to work
tirelessly toward making that future a reality.

Based on its corporate philosophy,
"Dedicated to the Fight against Disease and Pain,"
Ono Pharmaceutical has been delivering hope
to patients and their families
by creating innovative drugs.
New drugs are approved after overcoming
many challenges and failures.
We believe that taking on new challenges in this manner will lead to a bright future,
and we will continue to work tirelessly toward making that future a reality.

About our Corporate Slogan